Originally posted by mac3
There you go Nutler,
It is posted on Biotrons website, so pretty authentic,
"He is a Master Stockbroker" as below;
Mr Robert B Thomas BEc, MSDIA, SF Fin, FICD Independent and Non-Executive Director Mr Thomas has over
35 years experience in the securities industry, with Potter Partners (now UBS), County NatWest and Citigroup.He is the Chairman of Starpharma Holdings Limited and a Director of Aus Bio Limited, Heartware Inc, REVA Medical Limited and Virgin Australia Limited. He chairs Grahger Capital Securities, and is a Director of O’Connell Street Associates Pty Limited.Mr Thomas has a Bachelor of Economics from Monash University (1963–1966). He has been a member of the Securities Institute of Australia since 1976 and was appointed as a Fellow to the Institute in 1997.
He is a Master Stockbroker and is a Fellow of the Institute of Company Directors.Mr Thomas was appointed as a Director on 7 March 2012.
Sorry guys, I believe I failed to effectively convey my question in my earlier post. I did read the extract above and it’s actually specifically what prompted my line of reasoning.
I’ll have another crack with a direct approach to see if that lands with you guys or even works to create feed back that effects change in my ideas.
1. How many of you knew of the said Directors mastery of stockbrokering prior to the above (original post) being published to today, in this thread, and since re-inforcef.
2. What, if any speicific information are you aware relating to the directors strockbrokering career, investments or profitability are you aware of, other than the commentary in this thread and the source of the original extract above.
3. Relating to both your answers of the above questions, and the exposure to and participation in HC over the past 2-3 months, what do you make of he following...
...whilst I can’t lay claim to having read every single snippet of every post posted in relation to BIT here on HC however, I have read a significant amount, participated in almost evething thread, all whilst following my own sources of information outside of this Forum.
Taday is the 1st time, in let’s say (warning mad generalisation imminent) 100s of threads, 1000s of posts and 100,000s words said, witnessed the phrase “Master Stockbroker” and or that phrase being used in reference to the director we are discussion - whom has be discussed robustly on many occasions.
Why has this new narrative of emerged?
Is he no longer the Bio/Pharma influencer stated to be an asset to the cause?
Is the new narrative and or falling share price related.
Is the SP falling a direct result?
Or is this new master broker narrative simply emerging today in this discussion to allow for the deflation of the over exposed / under informed investors a subjective rationale to excuse their exit from this investment, with any the resulting financial outcomes (win, lose or draw)
